Preventing Cervical Cancer in India through Self-sampling (PCCIS)

  • Sustainable Development Goal :3 - Good Health & Well-Being
  • Gender Equality Marker :Gender Transformative (GE3)
  • Testing Country :India
  • Testing Period :15 months
  • Amount :$250,000

Ryerson tested the introduction of a self-sampling method, supported by a sexual health literacy intervention, to increase screening for Human Papilloma Virus (HPV) and cervical cancer among rural women in India. The project aims to facilitate timely screening for HPV and help to decrease cervical cancer mortality rates in areas where the Papanicolaou (Pap) test is not easily accessible to women.

Canadian SMO : Ryerson University
Local Partner(s) : Tata Memorial Hospital
Region : Asia
Theme : Health & Nutrition

< Back